Oxford Cannabinoid Technologies Holdings plc – Pre-Close Trading Update; US OTC QB Market Application & Notice of 2021 Final Results
Cannabis Law Report
AUGUST 23, 2021
Details of a presentation to investors via the InvestorMeet Platform will be announced shortly. At the end of the programme, Evotec will provide the Company with a submission-ready regulatory document which will be used for submissions to regulatory agencies, as well as drug-batch approved and ready for First Time in Human clinical trials.
Let's personalize your content